Clinical Trial Update: Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing human menopausal gonadotropin (HMG) to recombinant FSH (rFSH) in GnRH antagonist cycles for ovarian stimulation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Human menopausal gonadotropin (human menopausal gonadotropin)
• recombinant follicle-stimulating hormone (recombinant follicle-stimulating hormone)

Snippet

Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA | Conditions: Ovarian Stimulation | Phase 3 | Status: COMPLETED